Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTBVAC vs BCG in Newborns and Adults
NCT02729571Phase 2Completed
- Sponsor
- Biofabri
- Start
- Sep 2015
- Primary completion
- Sep 2016
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of mtbvac in Tuberculosis (TB), sponsored by Biofabri. Started Sep 2015; status: completed.
02
Drugs
mtbvac
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT02729571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02729571.